Propofol is an intravenous anaesthetic agent used for induction and maintenance of general anaesthesia. IV administration of propfol is used to induce unconsciousness after which anaesthesia may be maintained using a combination of medications. Recovery from propofol-induced anaesthesia is generally rapid and associated with less frequent side effects (e.g. drowsiness, nausea, vomiting) than with thiopental, methohexital, and etomidate. Propofol may be used prior to diagnostic procedures requiring anaesthesia, in the management of refractory status epilepticus, and for induction and/or maintenance of anaesthesia prior to and during surgeries.
Used for induction and/or maintenance of anaesthesia and for management of refractory status epilepticus.
Lotus Clinical Research, LLC, Pasadena, California, United States
Phoenix Clinical Research, LLC, Tamarac, Florida, United States
Plano Surgical Hospital, Plano, Texas, United States
Tianjin Union Medical Center, Tianjin, China
Beijing Tiantan Hospital, Capital Medical University, Beijing, Beijing, China
Washington University School of Medicine/Barnes-Jewish Hospital, Saint Louis, Missouri, United States
The First Affiliated Hospital of Xinjiang Medical University, Xinjiang, China
Inonu University, Malatya, Turkey
The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
General Hospital Maria Middelares, Ghent, Oost-Vlaanderen, Belgium
HKU Li Ka Shing Faculty of Medicine, Hong Kong, Guangdong, China
CIUSSS de l'Est de l'Ile de Montreal, Montreal, Quebec, Canada
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.